COMMUNIQUÉS West-GlobeNewswire

Drs. Javier, Perez, and Roth Collaborate with Castle Connolly Private Health Partners to Create Joint Concierge Program, Precision Concierge Physicians
30/09/2024
Precision Concierge Physicians — for patients who desire a personalized approach to their healthcare NAPLES, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Castle Connolly Private Health Partners, LLC (CCPHP), a leader in [...]
SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment
30/09/2024
FDA confirm s that SciSparc’s study may proceed only a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical [...]
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
30/09/2024
The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfort SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, [...]
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting
30/09/2024
Responder Analyses Show Treatment with Aficamten Demonstrated Improvements on Multiple Assessments of Clinical Significance to Cardiologists Results Simultaneously Published in the Journal of the American College of [...]
Sonnet BioTherapeutics Announces Launch of CEO Corner Platform
30/09/2024
CEO Corner segments to include additional discussion related to press releases, events, corporate updates and pipeline progress Provides interested parties the ability to ask questions and submit topics for future [...]
MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)
30/09/2024
Academic group to receive a total of $22 million for the trial LA JOLLA, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the [...]
AIM ImmunoTech Announces Pricing of $1.26 Million Registered Direct Offering
30/09/2024
OCALA, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional [...]
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
30/09/2024
SALT LAKE CITY, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly-owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
30/09/2024
CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
Digicann Ventures Signs Definitive Agreement for Proposed RTO Transaction with 3Win Corp.
28/09/2024
/ Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, Sept. 28, 2024 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: [...]
Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
28/09/2024
Updated Phase 1 data presented at ESH-iCMLf 26 th Annual John Goldman Conference Reported cumulative MMR rate of 44% (8/18) by 24 weeks, with stable or deepening responses between weeks 12 and 24, which continues to [...]
Montréal accueille le 4e Symposium international sur l’arthrogrypose congénitale multiple (ACM)
28/09/2024
MONTRÉAL, 28 sept. 2024 (GLOBE NEWSWIRE) -- Du 28 septembre au 1er octobre prochains, l’Hôpital Shriners pour enfants Canada sera l’hôte du 4ème symposium international sur l'arthrogrypose . Organisé en collaboration [...]
Montreal hosts the 4th International Symposium on Arthrogryposis Multiplex Congenita (AMC)
28/09/2024
MONTREAL, Sept. 28, 2024 (GLOBE NEWSWIRE) -- From September 28 to October 1, the Shriners Hospitals for Children - Canada will host the 4 th International Symposium on Arthrogryposis . Organized in collaboration with [...]
SOGC Calls for Vigilance and Continued Advocacy on International Safe Abortion Day
28/09/2024
OTTAWA, Ontario, Sept. 28, 2024 (GLOBE NEWSWIRE) -- As the world observes International Safe Abortion Day, the Society of Obstetricians and Gynaecologists of Canada (SOGC) is reaffirming its unwavering commitment to [...]
La SOGC lance un appel à la vigilance et à la poursuite des représentations pour protéger les droits des femmes à l'occasion de la Journée internationale de l'avortement sécuritaire
28/09/2024
OTTAWA, Ontario, 28 sept. 2024 (GLOBE NEWSWIRE) -- Alors que le monde entier observe la Journée internationale de l'avortement sécuritaire, la Société des obstétriciens et gynécologues du Canada (SOGC) réaffirme son [...]
Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results
28/09/2024
CARLSBAD, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]
BridgeBio Shares Recurrent Event Analysis of ATTRibute-CM, Demonstrating a 42% Reduction by Acoramidis on the Composite Endpoint of All-Cause Mortality and Recurrent Cardiovascular-related Hospitalization Events
28/09/2024
- Acoramidis treatment led to a highly significant reduction in all-cause mortality (ACM) and recurrent cardiovascular-related hospitalizations (CVH) at Month 30 compared with placebo - Additionally, results from a [...]
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
27/09/2024
Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today [...]
CARVYKTI® ▼ (ciltacabtagene autoleucel; cilta-cel) is the first cell therapy to significantly extend overall survival versus standard therapies for patients with multiple myeloma as early as second line
27/09/2024
45 percent reduction in risk of death achieved with cilta-cel versus standard therapies after three-year follow-up in landmark CARTITUDE-4 study 1 Data featured in a late-breaking oral presentation at the 2024 [...]

Pages